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V ibrio alginolyticus is a halophilic,  Gram-negative rod-shaped bacterium naturally distributed in 
marine and estuarine waters.  This bacterium is known 
as an opportunistic pathogen for both humans and 
marine animals [1-3].  In humans,  it causes medical 
problems such as wound infection [4-7],  ear infection 
[8-12],  and eye infection [13-15].  The incidence of 
V. alginolyticus infection was reported to be increasing,  
and this infection may develop into an emerging disease 
due to climate change issues [16].  A complete under-
standing of the virulence mechanism of V. alginolyticus 
is necessary to prevent future outbreaks.
The pathogenicity of V. alginolyticus has been 
described both in vivo (lethality in a mouse model) [17] 
and in vitro (cytotoxic activity toward several mamma-
lian cell lines) [18].  The killing potency shown in those 
studies indicated that V. alginolyticus possesses virulence 
factor(s) that allow infection through the ability to 
overcome antibacterial immune responses such as 
phagocytosis,  and the ability to obtain nutrition from 
the dead cells.  As such a virulence factor in V. alginolyt-
icus,  Zhao et al.  [17] reported that the deletion of type 
III secretion system (T3SS) apparatus gene reduces the 
cytotoxicity toward mammalian cell lines.  A T3SS is a 
syringe-like apparatus that introduces specific proteins 
known as effectors into the cytoplasm of eukaryotic host 
cells.  Injected effectors allow bacteria to manipulate the 
host cells’ functions and cause diseases [19-21].  A vari-
ety of effectors are known to show specific cytotoxicity 
mechanisms in various bacterial species,  but the effec-
tor of T3SS that is responsible for the cytotoxicity in 
V. alginolyticus has been unclear.
The V. alginolyticus T3SS gene cluster is evolutionally 
close to T3SS1 in V. parahaemolyticus,  which is domi-
nantly responsible for cytotoxicity [22].  Another T3SS 
in V. parahaemolyticus,  T3SS2,  which is involved in 
enterotoxicity,  is absent in V. alginolyticus.  Among the 
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The bacterium Vibrio alginolyticus,  an opportunistic pathogen in humans,  has a type III secretion system 
(T3SS) that is responsible for its cytotoxicity toward eukaryotic cells.  The effector of T3SS that is responsible for 
the cytotoxicity had not been identified.  Here we demonstrate that VepA,  a homolog of the T3SS effector in 
V. parahaemolyticus,  is required for cytotoxicity in V. alginolyticus.  VepA induces lysosomal membrane perme-
abilization,  and it allows the leakage of only small molecules into the cytosol.  Our findings revealed that VepA 
induces cathepsin-independent cell death in mammalian cells.  The ferrous ion,  one of the small molecules in 
the lysosome contents,  appears to be involved in the cell death caused by V. alginolyticus VepA.
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effectors of T3SS1 in V. parahaemolyticus,  VepA (which 
has also been referred to as VopQ and as VP1680) plays 
a significant role in its cytotoxicity [23 , 24].  Since V. 
alginolyticus has a gene encoding a VepA homolog in 
the T3SS gene cluster,  we hypothesized that the VepA 
homolog also has an important contribution to the 
cytotoxicity.
In this study,  we constructed a vepA-deletion 
mutant in V. alginolyticus to analyze its role in the cyto-
toxicity of V. alginolyticus.  We observed that V. algino-
lyticus infection led to size-specific lysosome membrane 
permeabilization (LMP) in a VepA-dependent manner.  
We also use our results in a discussion of why the 
small-molecule leakage from lysosomes is related to cell 
death in V. alginolyticus infection.
Materials and Methods
Bacterial strains, plasmids, and culture conditions.
The bacterial strains and plasmids used in this study are 
listed in Table 1.  We used V. alginolyticus ATCC 17749 
[25] as the parent strain for the construction of 
gene-deletion mutant.  We used the Escherichia coli 
DH5α [26] for general plasmid manipulation; E. coli 
DH5α(λpir) was used to amplify the R6K-origin-
containing plasmids,  and E. coli RHO3 [27] was used as 
a conjugation donor for V. alginolyticus.  V. alginolyticus 
strains were routinely cultured in Luria-Bertani (LB) 3% 
NaCl medium (1% tryptone,  0.5% yeast extract,  3% 
NaCl) at 37°C,  and the E. coli strains were grown in LB 
medium (Lennox) (1% tryptone,  0.5% yeast extract,  
0.5% NaCl) at 37°C.  E. coli RHO3 was grown in LB 
medium supplemented with 100 µg/ml 2, 6-diaminopi-
melic acid.  Chloramphenicol (30 µg/ml),  ampicillin 
(50 µg/ml),  or kanamycin (100 µg/ml) was added to 
grow bacteria harboring the plasmid containing the 
corresponding resistance gene.
HeLa cells were cultured in Dulbecco’s modified 
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Table 1　 Bacterial strains and plasmids
Strain/Plasmid Relevant Genotype or Properties Reference or Source
E. coli strains
　DH5α F－ Φ80lacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 
hsdR17 (rK－mK－) phoA supE44
[26]
　DH5α(λpir) DH5α λpir H.P. Schweizer
　RHO3 SM10(λpir) Δasd: FRT ΔaphA: FRT [27]
V. alginolyticus strains
　ATCC 17749 Wild-type strain [25]
　　ΔvepA ATCC 17749 ΔvepA This study
　　ΔvscC ATCC 17749 ΔvscC This study
　　ΔvepA/vepA ΔvepA harboring pOU550 This study
　　ΔvepA/vector ΔvepA harboring pHSG398T This study
Plasmids
　pGEM-T Easy AMPr; TA cloning vector Promega
　pSG76-C CMr; Suicide plasmid vector; I-SceI [28]
　pKU66 CMr; pSG76-C with oriT This study
　pHSG398 CMr; pUC-type cloning vector Takara Bio.
　pHSG398T CMr; pHSG398 with oriT This study
　pEX18Ap AMPr; cloning vector; sacB; oriT [30]
　pEX18Km KMr; pEX18Ap with AMPr replacement to KMr This study
　pHSG298 KMr; source of kanamycin resistance gene Takara Bio.
　pUC18T-mini-Tn7T-Gm AMPr,  GMr; source of oriT [29]
　pST76A-SceP AMPr; source of I-SceI [28]
　pOU246 AMPr; pGEM-T Easy with EF-Tu promoter and I-SceI This study
　pOU257 KMr; pEX18Km with EF-Tu promoter and I-SceI This study
　pOU549 CMr; pKU66 with ΔvepA recombinant DNA fragment This study
　pOU550 CMr; pHSG398T with vepA This study
　pOU553 CMr; pKU66 with ΔvscC recombinant DNA fragment This study
AMP,  ampicillin; CM,  chloramphenicol; GM,  gentamycin; KM,  kanamycin.
Eagle’s medium (DMEM,  Sigma,  St. Louis,  MO,  USA) 
supplemented with 10% (v/v) inactivated fetal bovine 
serum (FBS) (Biowest,  Nuaillé,  France) at 37°C under 
5% CO2.  DMEM or minimum essential medium/Earle’s 
balanced salts (MEM/EBSS,  Gibco,  Grand Island,  NY,  
USA) without phenol red supplemented with 10% (v/v) 
inactivated FBS was used during incubation in the 
infection experiment.
Construction of a mobilizable vector for gene 
replacement. We constructed a mobilizable vector 
for gene replacement carrying the recognition site of 
meganuclease I-SceI,  pKU66,  by inserting the oriT 
region into pSG76-C [28] at the NotI site.  We amplified 
the oriT region from pUC18T-mini-Tn7T-Gm [29] 
using primers P064 (5’-GCGGCCGCTATCAGAGC 
TTATCGGCCAG-3’; the underlining indicates a NotI 
site) and P065 (5’-GCGGCCGCGGGGATTCCTT 
AAGGTATAC-3’; the underlining indicates a NotI site).
Construction of mobilizable vectors for gene 
expression. We constructed pEX18Km by replacing 
the ampicillin resistance gene on pEX18Ap [30] with the 
kanamycin resistance gene at the AatII and AhdI sites.  
We amplified the kanamycin marker from pHSG298 
(Takara Bio,  Shiga,  Japan) using primers P394 
(5’-GACGTCGATCTGATCCTTCAACTCAG-3’; the 
underlining indicates an AatII site) and P395 (5’-GACT 
CCCCGTCTGCTCTGCCAGTGTTACAAC-3’ ; the 
underlining indicates an AhdI site).
We constructed pHSG398T by inserting oriT into the 
AflIII site of pHSG398 (Takara Bio).  The oriT region 
was amplified by using primers P127 (5’-ACATGT 
ATCAGAGCTTATCGGCCAG-3’; the underlining 
indicates an AflIII site) and P128 (5’-ACATGTGGGG 
ATTCCTTAAGGTATAC-3’; the underlining indicates 
an AflIII site).
Construction of an I-SceI expression vector. We 
amplified the promoter region of the elongation factor 
thermo unstable (EF-Tu) in V. alginolyticus I. 029 by 
using primers P406 (5’-GAATTCAGCGGGTTA 
CCCTGTACTAG-3’; the underlining indicates an 
EcoRI site) and P407 (5’-GATCGTGTTCCTTCC 
TAGTTATG-3’).
The I-SceI gene was amplified from pST76-ASceP 
[28] with the use of the primers P408 (5’-CATAACTA 
GGAAGGAACACGATCATGCATCAAAAAAACCA
GGTA-3’; the underlining indicates a sequence over-
lapping to the 3’ region of the EF-Tu promoter) and 
P409 (5’-CAAAGGGAAAACTGTCCATAC-3’).  The 
two DNA fragments were spliced by overlap extension 
polymerase chain reaction (PCR).  The recombinant 
fragment was ligated into pGEM-T Easy (Promega,  
Madison,  WI) to obtain pOU246.  We cloned an EcoRI-
SphI fragment of pOU246 carrying the I-SceI gene with 
the EF-Tu promoter into the same sites of pEX18Km,  
resulting in pOU257.
Construction of a vepA-deletion mutant and a 
vscC-deletion mutant. We constructed ∆vepA as 
described [28] with several modifications.  A DNA frag-
ment with the vepA-deletion was constructed by overlap 
extension PCR as described [31] used the following 
primers: P787 (5’-GGATCCAACGTGGAGTAAGGA 
TGTGAAAA-3’; underlining indicates a BamHI site),  
P788 (5’-TGAAATTACACCCAGCCTTCTGCGCTGA
TTTTTTGTGTTGTATTAACCAT-3’ ; underlining 
indicates complementary region to P789),  P789 
(5’-GCAGAAGGCTGGGTGTAATTTCA-3’) and P790 
(5’-GAGCTCGAAGTCACTGAAGAGAGATTTTC 
GA-3’; underlining indicates a SacI site).
We cloned this fragment into pKU66 at the BamHI 
and SacI sites,  resulting in pOU549.  E. coli RHO3 har-
boring plasmid pOU549 was conjugated with V. algino-
lyticus ATCC 17749,  and the resultant transconjugant 
was conjugated to E. coli RHO3 harboring pOU257.  The 
transconjugants were selected on LB 2% NaCl agar 
plates containing antibiotic for the responsible plasmid.  
The vepA-deletion was confirmed by colony PCR using 
primers P787 and P790,  and by sequencing of the PCR 
products.  The remaining pOU257 was eliminated by 
inoculation into LB 3% NaCl medium containing 5% 
sucrose.
The construction of ∆vscC was performed using the 
same method as that used for the ∆vepA construction.  
The primers used to amplify the vscC-deletion fragment 
were P793 (5’-GAATTCCGGTTGCGAAAGTATG 
GCAATG-3’; the underlining indicates an EcoRI site),  
P794 (5’-AGGAACAACACTCACTGCGCATA-3’),  
P795 (5’-TATGCGCAGTGAGTGTTGTTCCTCGCC
CTTCAGAGGAGTCTTAACC-3’; the underlining 
indicates complementary region to P794) and P796 
(5’-GGATCCGCAGATCGAGTTTCTGTGTTCGG-
3’; the underlining indicates a BamHI site).  This frag-
ment was cloned into pKU66 at EcoRI and BamHI sites,  
resulting in pOU553.  The vscC deletion was confirmed 
by colony PCR using primers P793 and P796 and by 
sequencing of the PCR products.
Construction of a vepA expression vector. We 
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amplified the DNA fragment containing vepA from the 
gDNA by using primers P791 (5’-GCTGAATTCAATG
GTTAATACAACACAAAAAATCAGCCAAAGC-
3’; underlining indicates an EcoRI site) and P792 
( 5 ’ - G C TG G ATC C T TAC AC C C AG C C T TC TG 
CCAAG-3’; underlining indicates a BamHI site).  The 
PCR product was cloned into EcoRI and BamHI sites of 
pHSG398T,  which yielded pOU550.
Cytotoxicity assay. HeLa cells were seeded into a 
96-well plate at 3 × 104 cells/well,  and then incubated at 
37°C under 5% CO2 for 48 h.  The cells were washed 
with DMEM or MEM/EBSS medium without phenol 
red,  and then infected with V. alginolyticus at a multi-
plicity of infection (MOI) of 100 for 4 h.  A ten-times 
dilution of V. alginolyticus at the optical density at 
600 nm (OD600) of 1.0 is equal to 3-4 × 108 CFU/ml on 
an LB 1% NaCl agar plate.  We added 10 µl of these 
dilution cultures to 3-4 × 104 of HeLa cell culture to 
obtain the MOI of 100.
We measured the release of lactate dehydrogenase 
(LDH) into the medium by using a Cytotoxicity 
Detection KitPLUS (LDH) (Roche,  Mannheim,  Germany) 
according to the manufacturer’s instructions.  The per-
centage of LDH release was calculated based on the 
following equation: [OD490 of experimental release − 
OD490 of spontaneous release]/(OD490 of maximum release 
− OD490 of spontaneous release) × 100.  The spontaneous 
release is the amount of LDH released from the cyto-
plasm of uninfected cells,  and the maximum release is 
the total amount of LDH released upon the complete 
lysis of uninfected cells.
AO relocation assay. The acridine orange (AO) 
relocation assay was performed as described [24].  We 
used fluorescence microscopy (Biozero BZ-8000,  
Keyence,  Tokyo,  Japan) to analyze the AO-stained cells.
Fluorescent-dextran translocation. Fluorescent-
dextran translocation was observed as described [32].  
Before infection,  HeLa cells were incubated in 100 µg/
ml fluorescein isothiocyanate (FITC)-dextran for 16 h.  
We analyzed fluorescent dextran in the HeLa cells by 
fluorescence microscopy.
Inhibition of cathepsin and reactive oxygen species 
(ROS), LMP induction, and iron chelation. HeLa 
cells were pretreated with 100 µM E-64d,  a broad- 
spectrum cathepsin inhibitor,  for 16 h before infection.  
The cells were challenged with 3 mM L-Leucyl-L-
Leucine methyl ester (LLOMe) for 4 h to induce LMP.  
To chelate iron,  we used 100 µM 2, 2’-bipyridyl (BIP).  
To inhibit reactive oxygen species (ROS),  we used 
5 mM N-acetyl cysteine (NAC) or 250 µM Trolox.
Statistical analysis. The two-tailed Student’s 
t-test was used for the statistical analyses.
Results
VepA contributes to HeLa cell cytotoxicity in V. 
alginolyticus infection. We chose V. alginolyticus 
strain ATCC 17749,  which was shown to be highly vir-
ulent in an in vivo infection model [18].  VepA 
(N646_0746) in this strain is homologous to that in V. 
parahaemolyticus,  with 88% sequence similarity (435 
aa/493 aa).
To examine the contribution of VepA to the cytotox-
icity toward human cells,  we performed the LDH 
release cytotoxicity assay after 4 h of bacterial infection 
against HeLa cells (Fig. 1).  The T3SS apparatus gene 
mutant,  ∆vscC,  showed significantly less cytotoxicity 
than the wild-type (WT).  ∆vepA also showed signifi-
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Fig. 1　 VepA contribution to cytotoxicity toward HeLa cells.  
HeLa cells were infected with the wild-type strain (WT),  a 
vscC-deletion mutant (ΔvscC),  a vepA-deletion mutant (ΔvepA),  
or a vepA-deletion mutant carrying a vepA-expression plasmid or 
the empty vector (ΔvepA/vepA or ΔvepA/vector,  respectively).  
We evaluated cytotoxicity at 4h after infection by measuring the 
amount of LDH released into the culture supernatant.  Data are 
mean±SD.  ＊＊＊p＜0.001.
cantly less cytotoxicity.  The vepA complimentary strain,  
∆vepA/vepA completely restored the cytotoxicity (simi-
lar to the WT),  whereas ∆vepA/vector did not.  To test 
the results of the LDH release cytotoxicity assay,  we also 
performed propidium iodine (PI) staining.  The results 
were similar to those of the LDH release cytotoxicity 
assay (data not shown).  These results indicate that 
mainly VepA is responsible for the cytotoxicity of V. 
alginolyticus.
VepA in V. alginolyticus induced lysosomal mem-
brane permeabilization (LMP). It was reported that 
V. parahaemolyticus VepA induces LMP in mammalian 
cells [24 , 33].  Here we therefore examined the integrity 
of lysosomes in V. alginolyticus-infected cells by using 
acridine orange (AO) (Fig. 2).  AO is a metachromatic 
dye that emits red fluorescence at low pH (e.g.,  in lyso-
somes) and emits green fluorescence at neutral pH (e.g.,  
in the cytosol) [34].
In uninfected HeLa cells,  we observed small red 
fluorescent dots,  which reflect an accumulation of the 
dye in lysosomes.  In the WT infection,  the appearance 
of red dots was disappeared and the intensity of the 
green fluorescence in the cytosol was increased.  In con-
trast,  in the ∆vepA infection,  the appearance of red dots 
was comparable to that in the uninfected cells,  and the 
green fluorescence enhancement was not observed.  In 
the ∆vepA/vepA infection,  the fluorescence pattern 
reverted to one similar to that obtained with the WT.  
These results indicate that V. alginolyticus infection 
induces the leakage of the lysosomal contents into the 
cytosol in a VepA-dependent manner.
We observed that infection with either V. alginolyti-
cus strain induced a morphological change of HeLa 
cells,  i.e.,  cell rounding (Fig. 2).  Since the ∆vepA infec-
tion also induced cell rounding,  we can safely assume 
that this change is not due to VepA.  On the other hand,  
the ∆vscC strain did not affect the cell morphology (data 
not shown).  Therefore,  this change might be caused by 
other T3SS effectors,  e.g.,  N646_0751,  the homologue 
of VopS in V. parahaemolyticus [35].
The VepA-induced LMP in V. alginolyticus was not 
due to a lysosomal membrane rupture. The molecu-
lar mass of AO is approx.  0.3 kDa.  To determine 
whether VepA induces the release of only small mole-
cules or lysosomal rupture,  we observed the LMP in 
V. alginolyticus infection using larger molecules:  
FITC-dextran,  with the molecular mass of 4 or 10 kDa.  
It is well known that such macromolecules can be 
loaded into lysosomes to yield green fluorescence punc-
tates while the lysosomes are intact.  When the lyso-
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Fig. 2　 AO relocation assays results.  HeLa cells were incubated with AO and then infected with the WT strain,  a vepA-deletion mutant 
(ΔvepA),  or a vepA-deletion mutant carrying a vepA-expression plasmid (ΔvepA/vepA) for 4h.  AO emits red ﬂuorescence in the lyso-
somes and green ﬂuorescence in the cytosol.
somes are ruptured,  the FITC-dextran is released into 
the cytosol to yield diffuse green fluorescence.
HeLa cells were treated with FITC-dextran for 16 h 
to allow lysosomal uptake before infection or challenge 
with an LMP inducer,  LLOMe.  When FITC-dextran 
with the molecular mass of 10 kDa was preloaded 
(Fig. 3A),  LLOMe-treated cells showed diffuse fluores-
cence enhancement in the cytosol.  In contrast,  the cells 
infected with the WT or ∆vepA did not exhibit the fluo-
rescence diffusion into the cytosol,  but the cells did 
show fluorescent punctates.  Our experiments using 
FITC-dextran with the molecular mass of 4 kDa gave 
the same pattern (Fig. 3B).  These results indicate that 
the VepA-mediated LMP allows the translocation of 
molecules smaller than 4 kDa.
VepA-dependent cytotoxicity is not due to lyso-
somal cathepsin. LMP-associated cell death is usu-
ally related to lysosomal cathepsin release [36].  Since 
the VepA-induced LMP in V. alginolyticus infection 
allowed the release of only molecules < 4 kDa,  we 
hypothesized that lysosomal proteases with the molecu-
lar sizes > 4 kDa (including cathepsins,  the molecular 
masses of which is approx.  30 kDa) could not pass 
through the lysosomal membrane.  To determine 
whether the VepA-mediated cell death is due to cathep-
sin release from lysosomes,  we examined the effect of a 
broad-spectrum cathepsin inhibitor,  E-64d,  on cell 
death.  HeLa cells were treated with E-64d for 16 h 
before challenge with LLOMe or a V. alginolyticus strain.  
The lysosomal rupture induced by LLOMe subsequently 
resulted in cell death,  as reported [36],  and cytotoxic-
ity was reduced by E-64d treatment as expected 
(Fig. 4A).  When the cells were challenged with the WT 
strain,  the cell death rates were similar regardless of the 
E-64d treatment (Fig. 4A).  These results suggest that 
cathepsin is not the major causative factor of V. algino-
lyticus cytotoxicity.
Since the lysosome is one of the iron-rich intracellu-
lar organelles,  VepA might allow excessive iron release 
into the cytosol to induce cell death via ROS [37].  To 
investigate the roles of iron and ROS in cell death in 
V. alginolyticus infection,  we compared their cytotoxic 
effects in the presence of an iron chelator,  BIP,  and an 
ROS scavenger,  NAC or Trolox.  In the presence of BIP,  
the cytotoxicity was significantly reduced.  However,  
after the ROS scavenger treatment,  the cytotoxicity was 
slightly reduced or not changed,  respectively (Fig. 4B).  
When we directly examined hydroxyl radicals by using 
hydroxyphenyl fluorescein,  we observed no fluores-
cence in V. alginolyticus-infected cells (data not shown).
Discussion
The opportunistic pathogen V. alginolyticus has an 
active T3SS that is involved in its cytotoxicity [3 , 17].  In 
V. parahaemolyticus,  a T3SS effector,  VepA,  makes the 
major contribution to the cytotoxicity.  Our present 
findings demonstrate that the VepA in V. alginolyticus 
plays a significant role in its cytotoxicity (Fig. 1).  Since 
the vepA gene is conserved in several Vibrio species [38],  
it is possible that VepA-induced cell death is a common 
pathogenic mechanism among the species.
Our present results obtained using an in vitro infec-
tion model also showed that V. alginolyticus induces the 
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Fig. 3　 LMP visualized by ﬂuorescent dextran release.  HeLa cells were incubated with 10-kDa (A) or 4-kDa (B) FITC-dextran for 16h 
and then challenged with LLOMe or infected with the WT strain,  vepA-deletion mutant (ΔvepA),  or vepA-deletion mutant carrying a 
vepA-expression plasmid (ΔvepA/vepA) for 4h.
leakage of the 0.3-kDa lysosomotropic dye AO into the 
cytosol in a VepA-dependent manner (Fig. 2).  
Molecules larger than 4 kDa were retained in the lyso-
somes (Fig. 3).  We thus speculate that V. alginolyticus 
VepA induces size-specific LMP.  These results are con-
sistent with those obtained by Sreelatha et al.  [33],  i.e.,  
V. parahaemolyticus VepA induces LMP,  which only 
allows the release of molecules < 4 kDa.  Sreelatha et al.  
also proposed that VepA forms pores with an estimated 
diameter of 18 Å in liposomes.  Further studies are nec-
essary to determine whether V. alginolyticus VepA forms 
such pores in the lysosomal membrane.
LMP results in cell death,  which is usually related to 
lysosomal cathepsin release [36].  Since V. alginolyticus 
VepA induced size-specific LMP,  i.e.,  < 4 kDa,  we can 
safely assume that this is not the case,  since lysosomal 
proteases (e.g.,  cathepsins) have much larger molecular 
masses at approx.  30 kDa.  To test this,  we used the 
broad-spectrum cathepsin inhibitor E-64d to determine 
whether it inhibits the cell death.  Since V. alginolyticus 
VepA induced cell death regardless of the presence of 
this inhibitor (Fig. 4A),  the cell death is caused by a 
factor(s) other than cathepsins.  We thus suspect that 
the involvement of lysosomal small molecules poten-
tially harmful to the cells is responsible for the VepA-
induced cell death.
The lysosome is a pool of redox-active iron capable 
of generating free radicals via the Fenton reaction [37].  
We used the iron chelator BIP to examine whether iron 
mediates the VepA-induced cell death.  Since iron che-
lation significantly reduced the cell death to a level that 
was almost the same as that observed with vepA-deleted 
V. alginolyticus infection,  it appears that iron is an 
important mediator of VepA-dependent cell death 
(Fig. 4B).  Our results support the observation by 
Matsuda et al.  [24] that an iron chelator partially 
reduced the cytotoxicity in V. parahaemolyticus infec-
tion.
Since it is well known that iron triggers cell death via 
ROS accumulation [37 , 39],  we examined the effects of 
ROS scavengers.  NAC inhibited the cell death only 
slightly,  but Trolox did not inhibit the cell death at all.  
Moreover,  the growth rate of V. alginolyticus was not 
affected by the presence of BIP,  NAC or Trolox.  We 
therefore propose that iron induces cell death without 
ROS accumulation in this infection model.  A study on 
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Fig. 4　 Cytotoxicity of V. alginolyticus infection in cathepsin inhibition,  iron chelation,  and ROS inhibition.  A,  HeLa cells were pre-
treated with E-64d (E) and then challenged with 3 mM LLOMe or infected with the WT strain for 4h; B,  HeLa cells were pretreated with 
an iron chelator (BIP) or an ROS scavenger (NAC or Trolox) and then infected with WT strain for 4h.  Data are mean±SD.  ＊＊p＜0.01,  
＊＊＊p＜0.001.
yeast demonstrated that iron overload stimulates the 
sphingolipid production that leads to cell death,  with-
out ROS accumulation [37].  Additional studies are 
required to elucidate the function of iron in VepA-
induced cell death.
In conclusion,  our experiments demonstrated that 
VepA induced cathepsin-independent cell death.  We 
also observed that VepA induced size-specific LMP that 
allows only small molecules to be released into the 
cytosol.  We propose that iron leakage from lysosomes 
plays an important role in this cell death mechanism.  
Further research is required to elucidate the underlying 
molecular mechanism,  which might provide insights 
into the development of novel therapeutics that target 
the VepA-related cell death mechanism.
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